JP2002516277A5 - - Google Patents

Download PDF

Info

Publication number
JP2002516277A5
JP2002516277A5 JP2000550480A JP2000550480A JP2002516277A5 JP 2002516277 A5 JP2002516277 A5 JP 2002516277A5 JP 2000550480 A JP2000550480 A JP 2000550480A JP 2000550480 A JP2000550480 A JP 2000550480A JP 2002516277 A5 JP2002516277 A5 JP 2002516277A5
Authority
JP
Japan
Prior art keywords
substituted
embedded image
group
aryl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000550480A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002516277A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/011490 external-priority patent/WO1999061020A1/en
Publication of JP2002516277A publication Critical patent/JP2002516277A/ja
Publication of JP2002516277A5 publication Critical patent/JP2002516277A5/ja
Pending legal-status Critical Current

Links

JP2000550480A 1998-05-22 1999-05-21 ＩｇＥのダウンレギュレータとしてのベンゾイミダゾールアナログ Pending JP2002516277A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8649498P 1998-05-22 1998-05-22
US60/086,494 1998-05-22
PCT/US1999/011490 WO1999061020A1 (en) 1998-05-22 1999-05-21 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE

Publications (2)

Publication Number Publication Date
JP2002516277A JP2002516277A (ja) 2002-06-04
JP2002516277A5 true JP2002516277A5 (enExample) 2006-07-20

Family

ID=22198947

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000550479A Pending JP2002516276A (ja) 1998-05-22 1999-05-21 ＩｇＥのモジュレータとしてのベンゾイミダゾール誘導体
JP2000550473A Withdrawn JP2002516274A (ja) 1998-05-22 1999-05-21 ＩｇＥ影響特性を有する化合物
JP2000550480A Pending JP2002516277A (ja) 1998-05-22 1999-05-21 ＩｇＥのダウンレギュレータとしてのベンゾイミダゾールアナログ

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2000550479A Pending JP2002516276A (ja) 1998-05-22 1999-05-21 ＩｇＥのモジュレータとしてのベンゾイミダゾール誘導体
JP2000550473A Withdrawn JP2002516274A (ja) 1998-05-22 1999-05-21 ＩｇＥ影響特性を有する化合物

Country Status (22)

Country Link
US (2) US6271390B1 (enExample)
EP (3) EP1079830A1 (enExample)
JP (3) JP2002516276A (enExample)
KR (1) KR100591652B1 (enExample)
CN (4) CN1219510C (enExample)
AT (1) ATE292465T1 (enExample)
AU (3) AU754943B2 (enExample)
BR (3) BR9910641A (enExample)
CA (3) CA2332985A1 (enExample)
CZ (2) CZ20004350A3 (enExample)
DE (1) DE69924607T2 (enExample)
ES (1) ES2241285T3 (enExample)
HU (3) HUP0102128A3 (enExample)
IL (3) IL139826A0 (enExample)
MX (3) MXPA00011467A (enExample)
NO (3) NO20005888L (enExample)
NZ (2) NZ508413A (enExample)
PL (3) PL345219A1 (enExample)
RU (2) RU2236220C2 (enExample)
UA (2) UA67775C2 (enExample)
WO (3) WO1999061020A1 (enExample)
ZA (3) ZA200007754B (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911462B2 (en) 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6919366B2 (en) 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
JP2002516276A (ja) * 1998-05-22 2002-06-04 アバニール・ファーマシューティカルズ ＩｇＥのモジュレータとしてのベンゾイミダゾール誘導体
CN1325380A (zh) * 1998-09-11 2001-12-05 味之素株式会社 苯衍生物和它们的药物用途
US6270746B1 (en) * 1999-02-17 2001-08-07 David H. Katz Assay for the identification of IgE antibody suppressors
UA72244C2 (en) * 1999-03-26 2005-02-15 Aryl-substituted pyrazols, imidazols, oxazols, thiazols, pyrrols and their use
CA2377771A1 (en) * 1999-07-01 2001-01-11 Ajinomoto Co., Inc. Heterocyclic compounds and medical use thereof
WO2001016091A1 (en) * 1999-09-01 2001-03-08 Ajinomoto Co.,Inc. Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof
US6759425B2 (en) 1999-10-21 2004-07-06 Avanir Pharmaceuticals Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
US20070208087A1 (en) 2001-11-02 2007-09-06 Sanders Virginia J Compounds, compositions and methods for the treatment of inflammatory diseases
DE60221804T2 (de) 2001-03-12 2008-05-15 Avanir Pharmaceuticals, San Diego Benzimidazolderivate zur ige-modulierung und zellproliferationshemmung
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
WO2003011219A2 (en) * 2001-07-27 2003-02-13 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto
EP1435947B1 (en) 2001-10-19 2007-08-15 Ortho-McNeil Pharmaceutical, Inc. 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
US20080081788A1 (en) * 2002-01-14 2008-04-03 Lipps Binie V Diagnosis and treatment for immunoglobulin E (IgE) implicated disorders
US20030157555A1 (en) * 2002-01-14 2003-08-21 Lipps Binie V. Diagnosis and treatment for immunoglobulin E ( IgE) implicated disorders
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
SI1511710T1 (sl) 2002-05-31 2014-04-30 Proteotech, Inc. Spojine, sestavki in postopki za zdravljenje amiloidnih bolezni in sinukleinopatij, kot je Alzheimerjeva bolezen, diabetes tipa 2 in Parkinsova bolezen
EP1388535A1 (en) 2002-08-07 2004-02-11 Aventis Pharma Deutschland GmbH Acylated arylcycloalkylamines and their use as pharmaceuticals
US7425620B2 (en) 2002-08-14 2008-09-16 Scott Koenig FcγRIIB-specific antibodies and methods of use thereof
WO2004024655A2 (en) 2002-09-12 2004-03-25 Avanir Pharmaceuticals Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
WO2004041280A1 (en) * 2002-11-02 2004-05-21 Kyung-Lim Lee Composition for preventing secretion of immunoglobulin e-dependent histamine releasing factor
GB2397301A (en) * 2003-01-14 2004-07-21 Novo Pharmaceuticals Ltd De Substituted 1,3,5-triazine derivatives
US7132440B2 (en) 2003-04-17 2006-11-07 Janssen Pharmaceutica, N.V. Substituted benzimidazoles and imidazo-[4,5]-pyridines
WO2005013950A2 (en) * 2003-08-08 2005-02-17 Avanir Pharmaceuticals Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
TWI368507B (en) 2004-02-20 2012-07-21 Boehringer Ingelheim Int Viral polymerase inhibitors
AU2005245412B2 (en) * 2004-05-12 2011-08-04 Protamed, Inc. Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
CA2572218C (en) 2004-06-30 2013-06-11 Janssen Pharmaceutica, N.V. Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
CA2627722A1 (en) † 2005-10-31 2007-06-21 Merck & Co., Inc. Cetp inhibitors
EP1790345A1 (en) * 2005-11-02 2007-05-30 Esbatech AG Triazin beta-secretase inhibitors
AU2006336504C9 (en) * 2005-12-28 2015-05-14 Vertex Pharmaceuticals Incorporated 1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
US7671221B2 (en) * 2005-12-28 2010-03-02 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
PT2029173T (pt) 2006-06-26 2016-11-02 Macrogenics Inc Anticorpos específicos fc rib e seus métodos de uso
WO2010045633A2 (en) * 2008-10-17 2010-04-22 National Jewish Health Measurement and analysis of leukotrienes
CN102264737A (zh) 2008-12-23 2011-11-30 雅培制药有限公司 抗病毒化合物
MX2011006333A (es) 2008-12-23 2011-06-27 Abbott Lab Compuestos antivirales.
RU2541571C2 (ru) 2009-04-15 2015-02-20 Эббви Инк. Противовирусные соединения
US8716454B2 (en) 2009-06-11 2014-05-06 Abbvie Inc. Solid compositions
US9394279B2 (en) 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
UA118080C2 (uk) 2009-06-11 2018-11-26 Еббві Айрленд Анлімітед Компані Противірусні сполуки
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
JP5690839B2 (ja) * 2009-12-04 2015-03-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン産生のベンゾイミダゾール阻害薬
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
ES2587232T3 (es) * 2010-07-20 2016-10-21 Vestaron Corporation Triazinas y pirimidinas insecticidas
EP2632915B1 (en) 2010-10-29 2015-08-12 Boehringer Ingelheim International GmbH Benzimidazole inhibitors of leukotriene production
US8772304B2 (en) 2010-11-01 2014-07-08 Boehringer Ingelheim International Gmbh Benzimidazole inhibitors of leukotriene production
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US9034832B2 (en) 2011-12-29 2015-05-19 Abbvie Inc. Solid compositions
US11484534B2 (en) 2013-03-14 2022-11-01 Abbvie Inc. Methods for treating HCV
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
WO2019018562A1 (en) 2017-07-19 2019-01-24 Ideaya Biosciences, Inc. AMIDO COMPOUND AS MODULATORS OF AHR
PE20211644A1 (es) 2018-09-18 2021-08-24 Terns Inc Compuestos para tratar ciertas leucemias
CN110054558B (zh) * 2019-05-16 2022-03-25 海门瑞一医药科技有限公司 一种1-三氟甲基环丙烷-1-甲酸的制备方法
CN112441983B (zh) * 2019-08-29 2023-09-15 山东福长药业有限公司 一种基于苯并咪唑取代的硝基苯的化合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017610A (en) * 1957-03-15 1962-01-16 Curtiss Wright Corp Electronic data file processor
US4939133A (en) 1985-10-01 1990-07-03 Warner-Lambert Company N-substituted-2-hydroxy-α-oxo-benzeneacetamides and pharmaceutical compositions having activity as modulators of the arachidonic acid cascade
LU86258A1 (fr) 1986-01-21 1987-09-03 Rech Dermatologiques C I R D S Composes benzamido aromatique,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
US4744026A (en) * 1986-04-11 1988-05-10 American Telephone And Telegraph Company, At&T Bell Laboratories Methods and apparatus for efficient resource allocation
IT1232252B (it) 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
EP0428939B1 (de) * 1989-11-21 1996-01-17 Bayer Ag Cumarinderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und Thiazolyl-essigsäurederivate als Zwischenprodukte
EP0469477B1 (en) 1990-08-02 1995-09-20 F. Hoffmann-La Roche Ag Antiallergic combination
IE71647B1 (en) 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.
ES2102036T3 (es) 1992-06-15 1997-07-16 Celltech Therapeutics Ltd Derivados con grupo fenilo trisustituido utilizados como inhibidores selectivos de la fosfodiesterasa iv.
US5521813A (en) * 1993-01-15 1996-05-28 Strategic Weather Services System and method for the advanced prediction of weather impact on managerial planning applications
US5496826A (en) * 1994-09-02 1996-03-05 Bristol-Myers Squibb Company Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides
JP3223090B2 (ja) * 1994-12-27 2001-10-29 三井化学株式会社 フェニルベンズイミダゾール誘導体
US5821258A (en) * 1994-12-27 1998-10-13 Mitsui Chemicals, Inc. Phenylbenzimidazole derivatives
RU2084451C1 (ru) * 1995-10-17 1997-07-20 Акционерное общество закрытого типа "Алмазный Центр" Способ получения 2-фенилбензимидазола
AU4988997A (en) * 1996-10-23 1998-05-15 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
US6988076B2 (en) * 1997-05-21 2006-01-17 Khimetrics, Inc. Strategic planning and optimization system
JP2002516276A (ja) * 1998-05-22 2002-06-04 アバニール・ファーマシューティカルズ ＩｇＥのモジュレータとしてのベンゾイミダゾール誘導体
US6910017B1 (en) * 1999-03-05 2005-06-21 Profitlogic, Inc. Inventory and price decision support
US6405175B1 (en) * 1999-07-27 2002-06-11 David Way Ng Shopping scouts web site for rewarding customer referrals on product and price information with rewards scaled by the number of shoppers using the information
US6546387B1 (en) * 1999-11-15 2003-04-08 Transcom Software Inc. Computer network information management system and method using intelligent software agents
US20020042739A1 (en) * 2000-03-13 2002-04-11 Kannan Srinivasan Method and system for creating and administering internet marketing promotions
US20020023001A1 (en) * 2000-07-11 2002-02-21 Mcfarlin James A. Method and apparatus for online creation and sale of custom local store marketing materials
AU2002219791A1 (en) * 2000-11-15 2002-05-27 Manugistics Atlanta, Inc. Promotion pricing system and method
US20020198794A1 (en) * 2001-06-21 2002-12-26 Williams Edward P. Inventory management system for determining suggested part stocking levels for a vehicle dealer

Similar Documents

Publication Publication Date Title
JP2002516277A5 (enExample)
JP2002516276A5 (enExample)
RU2000129523A (ru) Аналоги бензимидазола в качестве понижающих регуляторов ige
JP2006503048A5 (enExample)
JP2006512293A5 (enExample)
US20110021509A1 (en) Pde10 inhibitors and related compositions and methods
JPH08259567A (ja) ピラゾロピリミジン類およびピロロピリミジン類によるニューロン疾患およびその他疾患の治療方法
RU98106501A (ru) Производные-хинолин-2(1н)-она в качестве антагонистов серотонина
KR960010000A (ko) 종양괴사인자(tnf)생성 저해제로서의 카테콜 디에테르 화합물
JP2002534523A5 (enExample)
JP2011507878A5 (enExample)
CA2520124A1 (en) Use of benzazole compounds for immunopotentiation
ZA200205660B (en) Corticotropin releasing factor antagonists.
JP2008503585A5 (enExample)
CA2225555A1 (en) Quinolones and their therapeutic use
JP2004501930A5 (enExample)
JP2011500544A5 (enExample)
JP2004531531A5 (enExample)
NO20041631L (no) Piperazinderivater med CCR1 reseptor antagonist
EP2310016A1 (en) Pde10 inhibitors and related compositions and methods
CA2475619A1 (en) Piperidine derivatives
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
RU2010112450A (ru) Производные хиназолинона, полезные в качестве ванилоидных антагонистов
CA2474262A1 (en) Short-acting sedative hypnotic agents for anesthesia and sedation
CA2405971A1 (en) New piperazine and piperidine compounds